Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Learn about the credit cards that offer the highest cash back rates. Make informed choices to maximize your rewards and savings.
25,960 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
In a market rattled by softer data, Coca-Cola’s traditional strengths keep drawing new and seasoned investors alike. ...
NVIDIA has retreated from its AI-driven highs, creating a potential buying opportunity. This guide explains why the s...
A leading hedge fund just disclosed a sizable new stake in Disc Medicine. This article breaks down what Disc Medicine...
EVgo’s growth hinges on expanding its fast-charging network and capitalizing on policy support. This article outlines...
As May 2026 unfolds, smart investors are looking for durable growth in healthcare. Here are three standout names, why...
CoreWeave trades around $100 as a massive backlog tests cash-generation prospects. Q1 results show strong revenue gro...
A private equity buyer has acquired the publishing stake in two Taylor Swift co-written hits, signaling a new frontie...
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Lantheus is steering a strategic shift toward PET radiodiagnostics, aiming to unlock new growth. This article breaks ...
AT&T's AI-driven customer app sparked a notable move in the stock market today, march, as investors weigh tech-enable...
A single AI stock could outperform the rest on Nasdaq by the end of 2026. This article breaks down why that might hap...